Wells Fargo
AIM

Wells Fargo’s AIM ImmunoTech AIM Stock Holding History

Wells Fargo’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$11 – 7415
2025
Q3 		$11 Hold
4
– – ﹤0.01% 6837
2025
Q2 		$35 Hold
4
– – ﹤0.01% 6655
2025
Q1 		$49 Hold
4
– – ﹤0.01% 6459
2024
Q4 		$79 Hold
4
– – ﹤0.01% 6445
2024
Q3 		$108 Sell
4
-7
-64% -$233 ﹤0.01% 6272
2024
Q2 		$427 Buy
11
+3
+38% +$127 ﹤0.01% 6158
2024
Q1 		$353 Buy
8
+1
+14% +$41 ﹤0.01% 6366
2023
Q4 		$328 Hold
7
– – ﹤0.01% 6482
2023
Q3 		$330 Hold
7
– – ﹤0.01% 6451
2023
Q2 		$502 Hold
7
– – ﹤0.01% 6488
2023
Q1 		$315 Hold
7
– – ﹤0.01% 6651
2022
Q4 		$227 Hold
7
– – ﹤0.01% 6590
2022
Q3 		$0 Sell
7
-100
-93% -$7K ﹤0.01% 7985
2022
Q2 		$8K Buy
107
+4
+4% +$384 ﹤0.01% 5870
2022
Q1 		$11K Sell
103
-15
-13% -$1.29K ﹤0.01% 6253
2021
Q4 		$10K Buy
118
+10
+9% +$1.55K ﹤0.01% 6562
2021
Q3 		$22K Hold
108
– – ﹤0.01% 5953
2021
Q2 		$23K Buy
108
+70
+184% +$15K ﹤0.01% 5854
2021
Q1 		$9K Sell
38
-368
-91% -$83.1K ﹤0.01% 6393
2020
Q4 		$73K Sell
406
-22
-5% -$4.4K ﹤0.01% 5467
2020
Q3 		$92K Buy
428
+57
+15% +$14.2K ﹤0.01% 5304
2020
Q2 		$91K Buy
371
+360
+3,273% +$87.4K ﹤0.01% 5266
2020
Q1 		$3K Buy
+11
New +$1.73K ﹤0.01% 5977
2018
Q1 		– Sell
-5
Closed -$7K – 6835
2017
Q4 		$7K Hold
5
– – ﹤0.01% 6010
2017
Q3 		$6K Buy
+5
New +$8.77K ﹤0.01% 6005
2017
Q2 		– Hold
0
– – – 6805
2017
Q1 		– Hold
0
– – – 6818
2016
Q1 		– Hold
0
– – – 6834
2015
Q4 		– Hold
0
– – – 6820
2015
Q3 		– Hold
0
– – – 6038
2015
Q2 		– Hold
0
– – – 6208
2015
Q1 		– Hold
0
– – – 6025
2014
Q4 		– Hold
0
– – – 5999
2014
Q3 		– Hold
0
– – – 5974
2014
Q2 		– Hold
0
– – – 5931
2014
Q1 		– Hold
0
– – – 5616
2013
Q4 		– Hold
0
– – – 5520
2013
Q3 		– Hold
0
– – – 5500
2013
Q2 		– Hold
0
– – – 5435

Other funds holding AIM

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CB
Community Bank Dewitt, New York $926M AUM 31.78% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

Wells Fargo's AIM Position: Q4 2025 in Review

Wells Fargo sold out of AIM ImmunoTech (AIM) in Q4 2025, closing a stake of 4 shares — an estimated $11 sold.

Wells Fargo first reported a position in AIM in Q3 2017 and held it in 25 quarters. The position peaked at $92K in Q3 2020. 13 funds tracked by Wall St. Rank hold AIM as of Q4 2025.

  • Wells Fargo reported no remaining AIM ImmunoTech position as of Q4 2025 after selling out during the quarter.
  • Wells Fargo sold 4 AIM ImmunoTech shares in Q4 2025, an estimated $11.
  • Wells Fargo first reported a position in AIM ImmunoTech in Q3 2017 and held it in 25 quarters.
  • Wells Fargo's AIM ImmunoTech position peaked at $92K in Q3 2020.
  • 13 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.